menu
    • menu

    Company profile for InnoCare Pharma

    NEW Drugs in Dev: 20
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical stage biopharmaceutical company committed to discovering, developing and commercializing best-in-class and/or first-in-class drugs for the treatment of cancer and autoimmune diseases. Led by a world-class management team of seasoned industry executives, we have built a fully integrated biopharmaceutical platform with strong in-house R&D capabilities. Our vision is to become a global biopharmaceutical leader t...
    We are a clinical stage biopharmaceutical company committed to discovering, developing and commercializing best-in-class and/or first-in-class drugs for the treatment of cancer and autoimmune diseases. Led by a world-class management team of seasoned industry executives, we have built a fully integrated biopharmaceutical platform with strong in-house R&D capabilities. Our vision is to become a global biopharmaceutical leader that develops anddelivers innovative therapies for patients worldwide. We have built a fully integrated platform that covers the entire spectrum of drug discovery and development functionalities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InnoCare PharmaChina Flag
    Country
    Country
    China
    Address
    Address
    Building 8, No. 8 Life Science Park Road, Zhongguancun Life Science Park, Chan...
    Telephone
    Telephone
    +86 10 66609999
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.innocarepharma.com/index.html
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    InnoCare Get NDA Acceptance for Orelabrutinib in Thrombocytopenia
    InnoCare Get NDA Acceptance for Orelabrutinib in Thrombocytopenia

    28 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/28/3302595/0/en/innocare-announces-the-acceptance-of-new-drug-application-for-orelabrutinib-in-primary-immune-thrombocytopenia-in-china.html

    GLOBENEWSWIRE
    28 May 2026
    Share Share
    Innocare Announces Approval Of Orelabrutinib In Australia
    Innocare Announces Approval Of Orelabrutinib In Australia

    27 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/27/3301710/0/en/innocare-announces-approval-of-orelabrutinib-in-australia.html

    GLOBENEWSWIRE
    27 May 2026
    Share Share
    InnoCare Doses 1st Patient in Oral IL-17 Inhibitor Phase 1 Trial
    InnoCare Doses 1st Patient in Oral IL-17 Inhibitor Phase 1 Trial

    13 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/13/3293904/0/en/innocare-announce-first-subject-dosed-in-phase-1-clinical-trial-of-icp-054-a-novel-potentially-best-in-class-oral-il-17aa-af-inhibitor.html

    GLOBENEWSWIRE
    13 May 2026
    Share Share
    Innocare Reports Robust Revenue Growth In 2026 Q1
    Innocare Reports Robust Revenue Growth In 2026 Q1

    23 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/23/3280053/0/en/innocare-releases-2026-q1-results-strong-revenue-growth-and-sustained-profitability.html

    GLOBENEWSWIRE
    23 Apr 2026
    Share Share
    Preclinical Data of Novel B7-H3 ADC ICP-B794 Unveil at 2026 AACR
    Preclinical Data of Novel B7-H3 ADC ICP-B794 Unveil at 2026 AACR

    21 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7196657

    FIRSTWORD PHARMA
    21 Apr 2026
    Share Share
    Innocare Achieves First Annual Profit In 2025 Results
    Innocare Achieves First Annual Profit In 2025 Results

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262266/0/en/InnoCare-Releases-2025-Results-and-Business-Highlights-Achieving-First-Annual-Profit.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search